Researchers investigated immune-related adverse effects and characteristics that may predict their incidence in patients receiving ICIs for gastrointestinal cancers.

Researchers have identified two microRNA that may predict which individuals with cancer are at elevated risk for ...

Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial (ClinicalTrials.gov Identifier: ...

The immune system, a complex network comprising cells, tissues, and organs, defends the body against pathogens and diseases. However, disruptions in immune homeostasis, especially the overactivated ...

This important study provides solid evidence to support the anti-tumor potential of citalopram, originally an anti-depression drug, in hepatocellular carcinoma (HCC). In addition to their previous ...

Avalo Therapeutics, Inc.’s AVTX share price has surged by 12.29%, which has investors questioning if this is right time to ...